What Is Driving the Rapid Growth of the Global Interventional Radiology Market?
The global interventional radiology market is witnessing significant growth, fueled by rising cases of chronic diseases, an aging population, and the growing preference for minimally invasive diagnostic and therapeutic procedures. Valued at USD 24.20 Billion in 2024, the market is projected to expand at a CAGR of 6.70% from 2025 to 2034, reaching approximately USD 46.29 Billion by 2034.
Interventional radiology (IR) combines medical imaging techniques with targeted therapeutic interventions, offering patients faster recovery, reduced hospital stays, and lower costs compared to traditional surgery. Its growing adoption across cardiology, oncology, nephrology, and urology is revolutionizing modern healthcare delivery systems worldwide.
Market Overview: A Shift Toward Image-Guided and Minimally Invasive Care
The interventional radiology market is transforming how diseases are diagnosed and treated. IR procedures rely on advanced imaging technologies such as CT scanners, MRI systems, angiography systems, and ultrasound imaging systems to guide minimally invasive interventions.
This shift is primarily driven by:
Increasing chronic disease prevalence (cardiovascular diseases, cancer, and kidney disorders).
Technological advancements in imaging and catheterization.
Patient preference for less invasive and outpatient-based procedures.
Cost-effective treatment approaches that reduce hospitalization and recovery time.
The expansion of AI-driven imaging analytics, robot-assisted procedures, and hybrid operating rooms is further fueling innovation in this field.
Interventional Radiology Market Size and Growth Forecast
2024 Market Size: USD 24.20 Billion
2034 Projected Size: USD 46.29 Billion
CAGR (2025–2034): 6.70%
The demand for precision-guided medical procedures continues to accelerate across hospitals and clinics. As healthcare systems shift toward value-based care, interventional radiology provides cost-efficient and high-precision treatment options, making it a preferred choice in both developed and emerging economies.
Key Market Trends
1. Rising Demand for Minimally Invasive Procedures
Patients and healthcare providers are increasingly preferring IR procedures due to their shorter recovery times, minimal scarring, and reduced post-operative complications.
2. Integration of Artificial Intelligence and 3D Imaging
AI-enabled systems now assist radiologists in detecting lesions, planning interventions, and improving procedural accuracy. The integration of 3D visualization tools enhances precision in procedures like angioplasty and embolization.
3. Growing Applications in Oncology
Interventional oncology, including tumor ablation, chemoembolization, and radioembolization, is one of the fastest-growing IR subfields. It enables targeted cancer therapy with fewer systemic side effects.
4. Expansion of Ambulatory Surgical Centers (ASCs)
The rising number of ASCs in developed countries has enhanced access to IR services outside hospitals, especially for vascular and musculoskeletal procedures.
5. Technological Upgrades and Product Launches
Manufacturers are focusing on digital imaging integration, hybrid systems, and portable IR devices, enhancing workflow efficiency and patient safety.
Market Segmentation
By Product
MRI Systems: Provide high-resolution imaging crucial for guiding complex interventions.
CT Scanners: Widely used for real-time navigation during procedures like biopsies and ablations.
Ultrasound Imaging Systems: Offer radiation-free imaging, commonly used in vascular access and obstetrics.
Angiography Systems: Essential for cardiovascular and neurovascular imaging.
Biopsy Devices: Enable accurate sampling with minimal invasiveness.
Fluoroscopy Systems: Provide continuous real-time imaging for complex interventions.
Others: Includes hybrid imaging systems and support accessories.
By Technology
Catheters: Used to deliver therapeutic agents directly to target sites.
Stents: Maintain vessel patency in cardiovascular and peripheral artery diseases.
Inferior Vena Cava (IVC) Filters: Prevent pulmonary embolisms.
Hemodynamic Flow Alteration (HFA) Devices: Regulate blood flow for enhanced treatment outcomes.
Angioplasty Balloons: Restore blood flow in blocked arteries.
Thrombectomy Systems: Remove clots in ischemic conditions.
Embolization Devices: Used to occlude abnormal vessels or tumors.
Biopsy Needles: Facilitate tissue collection for diagnostic purposes.
Accessories: Include guidewires and contrast injectors.
Others: Covers robotic-assisted tools and hybrid catheters.
By Procedure
Angioplasty: Widening of narrowed arteries using balloons or stents.
Angiography: Diagnostic imaging to assess vascular conditions.
Embolization: Blocking abnormal blood flow to treat tumors or aneurysms.
Thrombolysis: Dissolving blood clots to restore circulation.
Biopsy and Drainage: Extracting tissue or fluids for testing.
Vertebroplasty: Stabilizing spinal fractures.
Nephrostomy: Creating kidney drainage pathways.
Other Procedures: Includes ablations and vascular repairs.
By Application
Cardiology: Dominates the market due to the high prevalence of cardiovascular diseases.
Urology and Nephrology: Increasing demand for nephrostomy and embolization procedures.
Oncology: Rapidly growing due to targeted cancer therapies and minimally invasive tumor treatment.
Gastroenterology: Use in managing gastrointestinal bleeding and stent placements.
Obstetrics: Applications in uterine artery embolization and fertility-related interventions.
Others: Includes musculoskeletal and pulmonary applications.
By End User
Hospitals: The largest segment, equipped with advanced IR systems and hybrid surgical suites.
Clinics: Growing adoption for outpatient imaging and minor procedures.
Ambulatory Surgical Centres: Offering cost-effective and convenient access to IR services.
Others: Research and academic institutions focusing on IR innovations.
By Region
North America:
The largest regional market due to high healthcare spending, technological innovation, and the presence of leading companies like GE Healthcare, Siemens, and Philips.Europe:
Strong growth driven by supportive healthcare policies and increasing adoption of hybrid operating rooms.Asia Pacific:
The fastest-growing region, fueled by expanding healthcare infrastructure, rising awareness, and government investment in digital healthcare technologies.Latin America:
Increasing adoption of diagnostic imaging and IR procedures for oncology and cardiology.Middle East and Africa:
Emerging demand supported by modern hospital construction and growing medical tourism.
Market Growth Drivers
Increasing Chronic Disease Burden: Rising incidence of cardiovascular, oncological, and renal diseases is driving IR procedure volumes.
Advancements in Imaging Technology: Development of hybrid and AI-integrated imaging systems.
Growing Geriatric Population: Higher demand for minimally invasive solutions for age-related conditions.
Government Initiatives: Policies promoting early diagnosis and modern imaging infrastructure.
Shift Toward Outpatient Care: Increased adoption of cost-effective, day-care-based IR treatments.
Challenges in the Market
High Equipment Costs: Advanced imaging and navigation systems require substantial investment.
Skilled Workforce Shortage: Lack of trained interventional radiologists limits adoption in emerging economies.
Regulatory Hurdles: Stringent approval processes can delay product launches.
Reimbursement Limitations: Limited insurance coverage for certain minimally invasive procedures.
Recent Developments in the Interventional Radiology Market
Siemens Healthineers introduced advanced angiography systems with AI-driven imaging capabilities.
GE Healthcare launched new hybrid imaging suites for interventional oncology and neurology.
Medtronic expanded its thrombectomy and embolization product portfolios.
Canon Medical Systems unveiled a new line of ultrasound-guided interventional platforms.
Philips Healthcare partnered with hospitals to develop smart interventional suites integrating real-time data and imaging.
These developments highlight the industry’s focus on technological integration, patient safety, and procedural accuracy.
Key Companies in the Global Interventional Radiology Market
General Electric
Koninklijke Philips N.V.
Carestream Health
Hitachi, Ltd.
Hologic, Inc.
Shimadzu Corporation
Siemens Healthcare GmbH
Canon Medical Systems Corporation
Samsung Medison Co., Ltd.
Medtronic Plc
Agfa-Gevaert Group
Teleflex Incorporated
Analogic Corporation
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Trivitron Healthcare
Stryker Corporation
Olympus Corporation
Toshiba Medical Systems
These players are focusing on product innovation, strategic collaborations, and hybrid imaging technologies to strengthen their global market presence.
Future Outlook
The future of the interventional radiology market lies in automation, AI-based image analysis, and robot-assisted interventions. The shift toward personalized treatment and precision diagnostics will further enhance patient outcomes.
By 2034, interventional radiology will continue to expand into new therapeutic areas, driven by technology convergence between imaging, robotics, and data analytics.
Discover More Reports
Antimicrobial Hospital Curtains Market
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
